Cystic Fibrosis Foundation: Screening Improvement Program (SIP) Award Grant

The Cystic Fibrosis Foundation's Screening Improvement Program (SIP) Award aims to enhance early diagnosis of cystic fibrosis (CF) through improved newborn screening processes. This initiative emphasizes equitable screening practices for diverse populations and seeks innovative approaches to strengthen communication with primary care providers. Grants of up to $75,000 per year for two years are available to support projects that focus on algorithm transformation and best practices in screening, without funding clinical trials.

About the Cystic Fibrosis Foundation
The mission of the Cystic Fibrosis Foundation is to cure cystic fibrosis and to provide all people with CF the opportunity to lead long, fulfilling lives by funding research and drug development, partnering with the CF community, and advancing high-quality, specialized care. To achieve this mission, various types of grants and awards are offered to support meritorious research in CF.
Cystic Fibrosis Foundation: Screening Improvement Program (SIP) Award
Program and Award Overview
The overall purpose of the Screening Improvement Program (SIP) award is to catalyze efforts aimed at improving the screening system used for early diagnosis. This Request for Applications (RFA) is focused on improving equity and expediting the early diagnosis of CF through uniformly accelerated newborn screening (NBS) that includes as a priority addressing the special needs of the diverse populations of US infants. Applications that focus on enhancing the relationship or communication practices with primary care providerswill also receive consideration. However, this RFA is not intended to support projects devoted to clinical trials/interventions.
Applicants may request up to $75,000 per year for two (2) years, plus an additional twelve (12) percent of indirect costs may be requested per year for multi-center SIP applications to stimulate collaborations within states proposing algorithm transformation to best practices such as floating IRT cutoff values and/or expanded CFTR panels or sequencing.